Defender Capital’s Pfizer PFE Stock Holding History

Defender Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$477K	Hold	16,735	–	–	0.15%	28
2026 Q2	$403K	Hold	16,735	–	–	0.13%	29
2026 Q1	$470K	Hold	16,735	–	–	0.17%	22
2025 Q4	$417K	Buy	+16,735	New	+$422K	0.14%	27
2025 Q3	–	Sell	-16,735	Closed	-$406K	–	27
2025 Q2	$406K	Buy	16,735 +360	+2%	+$8.4K	0.14%	29
2025 Q1	$411K	Sell	16,375 -560	-3%	-$14.7K	0.16%	27
2024 Q4	$449K	Sell	16,935 -1,000	-6%	-$27.1K	0.17%	25
2024 Q3	$519K	Hold	17,935	–	–	0.17%	23
2024 Q2	$502K	Sell	17,935 -20	-0.1%	-$551	0.17%	22
2024 Q1	$498K	Buy	17,955 +20	+0.1%	+$555	0.17%	20
2023 Q4	$516K	Hold	17,935	–	–	0.18%	23
2023 Q3	$595K	Hold	17,935	–	–	0.22%	20
2023 Q2	$658K	Buy	+17,935	New	+$698K	0.23%	21
2022 Q1	–	Sell	-12,935	Closed	-$764K	–	40
2021 Q4	$764K	Buy	12,935 +2,697	+26%	+$134K	0.24%	21
2021 Q3	$440K	Buy	10,238 +38	+0.4%	+$1.68K	0.14%	30
2021 Q2	$399K	Buy	+10,200	New	+$397K	0.13%	28

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

Defender Capital's PFE Position: Q3 2026 in Review

Defender Capital held its Pfizer (PFE) position steady in Q3 2026 at 16,735 shares worth $477K. The position accounts for 0.15% of the portfolio, ranked #28.

Defender Capital first reported a position in PFE in Q2 2021 and has held it in 16 quarters since. The position peaked at $764K in Q4 2021. 551 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Defender Capital held 16,735 shares of Pfizer worth $477K as of Q3 2026.
Defender Capital left its Pfizer share count unchanged in Q3 2026.
Pfizer made up 0.15% of Defender Capital's portfolio in Q3 2026, its #28 holding.
Defender Capital first reported a position in Pfizer in Q2 2021 and has held it in 16 quarters since.
Defender Capital's Pfizer position peaked at $764K in Q4 2021.
551 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Defender Capital's 13F filing for Q3 2026, filed 1 Oct 2026.